PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION, CONTAINING RECEPTOR SIGNALING INHIBITOR
- 专利权人:
- NIIGATA UNIV
- 发明人:
- SHIMOHATA KIYOSHI,下畑 享良
- 申请号：
- JP2018132197
- 公开号：
- JP2018177809A
- 申请日:
- 2018.07.12
- 申请国别(地区):
- JP
- 年份:
- 2018
- 代理人:
- 摘要：
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of cerebral infarction, administrable even to patients after cerebral infarction acute stage passage.
SOLUTION: The therapeutic pharmaceutical composition for the treatment of cerebral infarction comprises a thrombolytic agent and a vascular endothelial growth factor (VEGF) receptor-signaling inhibitor. The therapeutic pharmaceutical composition for the treatment of cerebral infarction is, if necessary, administered into patients after cerebral infarction acute stage passage. The therapeutic pharmaceutical composition for the treatment of cerebral infarction, if necessary, contains a tissue type plasminogen-activator (t-PA) or its derivative.
COPYRIGHT: (C)2011,JPO&INPIT
- 来源网站：
- 中国工程科技知识中心
